These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1456820)

  • 1. [Search for inhibitors of West Nile virus among antibiotics].
    Azarova IA; Mishaeva NP; Votiakov VI; Golovneva GP
    Antibiot Khimioter; 1992 Aug; 37(8):29-31. PubMed ID: 1456820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiviral activity of an interferon inducer amixin in experimental West Nile Fever].
    Loginova SIa; Koval'chuk AV; Borisevich SV; Syromiatnikova SI; Borisevich GV; Pashchenko IuI; Khamitov RA; Maksimov VA; Shuster AM
    Vopr Virusol; 2004; 49(2):8-11. PubMed ID: 15106376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ribavirin prophylaxis and therapy of experimental West Nile fever].
    Loginova SIa; Borisevich SV; Pashchenko IuA; Bondarev VP
    Antibiot Khimioter; 2009; 54(11-12):17-20. PubMed ID: 20583562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of effective therapies against West Nile virus infection.
    Diamond MS
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):931-44. PubMed ID: 16307506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious disease. West Nile drugs, vaccine still years away.
    Enserink M
    Science; 2000 Nov; 290(5496):1483. PubMed ID: 11185501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro.
    Anderson JF; Rahal JJ
    Emerg Infect Dis; 2002 Jan; 8(1):107-8. PubMed ID: 11749765
    [No Abstract]   [Full Text] [Related]  

  • 7. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.
    Whitby K; Pierson TC; Geiss B; Lane K; Engle M; Zhou Y; Doms RW; Diamond MS
    J Virol; 2005 Jul; 79(14):8698-706. PubMed ID: 15994763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the chemotherapeutic activity of gentamicin sulfate].
    Lobuseva AN; Petrova MA; Pozdniakova VP; Berezina EK; Fomina IP
    Antibiotiki; 1976 Sep; 21(9):832-8. PubMed ID: 793517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunoglobulin as a treatment for West Nile virus infection.
    Agrawal AG; Petersen LR
    J Infect Dis; 2003 Jul; 188(1):1-4. PubMed ID: 12825164
    [No Abstract]   [Full Text] [Related]  

  • 10. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
    Parkinson T; Pryde DC
    Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and molecular characterization of West Nile virus NY 1999.
    Jordan I; Briese T; Lipkin WI
    Viral Immunol; 2000; 13(4):435-46. PubMed ID: 11192290
    [No Abstract]   [Full Text] [Related]  

  • 12. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.
    Nitsche C; Steuer C; Klein CD
    Bioorg Med Chem; 2011 Dec; 19(24):7318-37. PubMed ID: 22094280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Another case of West Nile fever in the Netherlands: a man with encephalitis following a trip to Canada].
    Gebhardt DO
    Ned Tijdschr Geneeskd; 2003 Jul; 147(27):1336; author reply 1336. PubMed ID: 12868166
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic systems of West Nile virus and their potential applications.
    Shi PY
    Curr Opin Investig Drugs; 2003 Aug; 4(8):959-65. PubMed ID: 14508880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of RNA interference to prevent lethal murine west nile virus infection.
    Bai F; Wang T; Pal U; Bao F; Gould LH; Fikrig E
    J Infect Dis; 2005 Apr; 191(7):1148-54. PubMed ID: 15747251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ChimeriVax-West Nile vaccine.
    Hall RA; Khromykh AA
    Curr Opin Mol Ther; 2007 Oct; 9(5):498-504. PubMed ID: 17932814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue.
    Behnam MA; Graf D; Bartenschlager R; Zlotos DP; Klein CD
    J Med Chem; 2015 Dec; 58(23):9354-70. PubMed ID: 26562070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. West Nile virus.
    Kramer LD; Li J; Shi PY
    Lancet Neurol; 2007 Feb; 6(2):171-81. PubMed ID: 17239804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course.
    Lewis M; Amsden JR
    Pharmacotherapy; 2007 Mar; 27(3):455-8. PubMed ID: 17316156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.